Early Switch From Intravenous to Oral Antibiotics and Early Hospital Discharge
Open Access
- 8 November 1999
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 159 (20) , 2449-2454
- https://doi.org/10.1001/archinte.159.20.2449
Abstract
IT IS ESTIMATED that half a million patients with community-acquired pneumonia (CAP) are hospitalized every year in the United States.1 The initial treatment of these patients typically includes the use of empiric intravenous antibiotics for likely pulmonary pathogens.2 Although some physicians believe the standard of care should consist of at least 7 days of intravenous antibiotic therapy,3 recent clinical trials indicate that antibiotic therapy can be safely changed from intravenous to oral (switch therapy) once the hospitalized patient with CAP shows evidence of clinical improvement.4-8This publication has 5 references indexed in Scilit:
- Sequential Therapy With Cefuroxime Followed by Cefuroxime Axetil in Community-Acquired PneumoniaChest, 1997
- A Prediction Rule to Identify Low-Risk Patients with Community-Acquired PneumoniaNew England Journal of Medicine, 1997
- The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort studyArchives of internal medicine (1960), 1997
- Evaluation of a pneumonia practice guideline in an interventional trial.American Journal of Respiratory and Critical Care Medicine, 1996
- Switch Therapy in Adult Patients with PneumoniaClinical Pulmonary Medicine, 1995